With Disease Agnostic Approach, QBI is Accelerating Ambitious Science
The Quantitative Biosciences Institute attracts investigators on the basis of the tools and techniques they employ, rather than the diseases they study.
University of California San Francisco
Give to UCSFThe Quantitative Biosciences Institute attracts investigators on the basis of the tools and techniques they employ, rather than the diseases they study.
A user-friendly website on advance care planning, as well as easy-to-read advance directives, can be highly effective in empowering older adults to plan for their future medical care.
Researchers have shown that the earliest stages of the brain degeneration associated with Alzheimer’s disease are linked to neuropsychiatric symptoms.
In DNA sequencing study of TD, UCSF researchers and their collaborators have unearthed new data suggesting a potential role for disruptions in cell polarity in the development of this condition.
A $20 million gift from longtime UCSF donors Dagmar Dolby and her son, David, will establish the UCSF Dolby Family Center for Mood Disorders within the Department of Psychiatry.
A new study has identified at-risk populations for whom depression screening combined with hazardous alcohol use screening could detect depressive symptoms that might otherwise go untreated.
As the low-carbohydrate, high-fat ketogenic, or “keto,” diet becomes more popular, scientists at UCSF are among those working to study its potential health benefits and risks.
A new UC San Francisco study has discovered a key biological difference in how people of European and Chinese descent put on weight — a finding that could help explain why Asians often develop type 2 diabetes at a much lower body weight than Caucasians.
UCSF researchers discovered fully formed gut and skin cells in the thymus, the organ responsible for training the T cells of the immune system not to attack the body’s own tissues.
People with severe mental illness are more than twice as likely to have Type 2 diabetes, with even higher risks among patients who are African American or Hispanic, according to a new study led by UCSF.
The journey from discovering and developing effective, precise medications to using them correctly and safely in patients is hardly fast and easy. Nor is it a straight shot. Scientists in the UCSF School of Pharmacy are challenging the status quo every step of the way.
Smoking cessation intervention for young adults conducted on Facebook found smokers are 2.5 times more likely to quit with the Facebook-based treatment than if they were referred to an online program.
In just the last few years, Zachary Knight’s research has upended textbook theories of hunger and thirst.
Automated breast-density evaluation was just as accurate in predicting women’s risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists.
Frances McDormand, David Strathairn and Marjolaine Goldsmith came to UCSF to read scenes from Sophocles’ Ajax – a 2,500-year-old tragedy about the suicide of a great warrior.
In the absence of rigorous preclinical testing from the FDA, health systems should carefully scrutinize digital tools that interact with electronic health records to recommend patient diagnoses or therapies.
A type of AI known as advanced machine learning can classify essential views from heart ultrasound tests faster, more accurately and with less data than board-certified echocardiographers.
Irregular heart impulses that lead to stroke can be detected using a smartwatch with a specially designed application, a finding that could eventually lead to new ways to screen patients for earlier treatment.
Samsung Electronics Co., Ltd. and UCSF have announced the launch of My BP Lab, a jointly developed smartphone research app to help users monitor their blood pressure and stress levels.
Office visits offer doctors only a snapshot of chronic conditions. That’s where new mobile health-tracking technology can make a real difference, providing detailed and long-term health data for each patient.
A new study shows that an immune signal named interleukin 33 plays a crucial role in allowing the brain to maintain the optimal number of synapses during the development of the central nervous system.
Type 2 diabetes is known to be a risk factor for bone fractures – but exactly how diabetes makes bones more fragile has been unclear.
UCSF researchers have discovered a new biological pathway in fat cells that could explain why some people with obesity are at high risk for metabolic diseases such as type 2 diabetes.
More and more, the promise of EHRs transforming data into knowledge is beginning to bear fruit.
UCSF researchers have discovered that the brain’s ability to regulate body weight depends on a novel form of signaling in the brain’s “hunger circuit” via antenna-like structures on neurons called primary cilia.
Anna Molofsky is researching how synapses pruning and formation occur normally during brain development in the hope of determining how subtle shifts in balance lead to neurodevelopmental disorders.
UCSF: The Campaign is taking on the world’s most complex health challenges, powered by an exceptional community of mavericks, innovators, and advocates. Together we will make the Bay Area and our world healthier for all.
For the third consecutive year, UCSF is co-sponsoring the Precision Medicine World Conference in January 2018 to share the latest in the rapidly evolving space.
Whether you are seeing them for the first time or coming back for another look, check out the most popular scientific stories from UC San Francisco from the past year.
A tiny implant developed in the lab of Tejal Desai promises to simplify how glaucoma drugs are administered, making life easier for aging patients.